Inhibin is a glycoprotein hormone produced primarily by ovarian granulosa cells that selectively suppresses follicle-stimulating hormone secretion from the anterior pituitary. The two principal forms, inhibin A and inhibin B, vary across the ovarian cycle and participate in feedback regulation of follicular development.
Inhibin is a glycoprotein hormone produced within the gonads that plays an important role in regulation of the hypothalamic-pituitary-gonadal axis. In the ovaries, inhibin is produced predominantly by granulosa cells and acts principally on the anterior pituitary to suppress secretion of follicle-stimulating hormone (FSH).
Two major biologically active forms are recognized: inhibin A and inhibin B. Their concentrations vary during the ovarian cycle because they are associated with different stages of follicular and luteal activity. Inhibin B is particularly associated with developing follicles during the follicular phase, while inhibin A becomes prominent during the luteal phase and is produced substantially by the corpus luteum.
Through selective regulation of FSH, inhibin contributes to the coordination of follicular recruitment, dominant follicle development, ovarian steroidogenesis, and the cyclic relationship between the ovaries and anterior pituitary.
Inhibin belongs to the transforming growth factor beta (TGF-β) superfamily of signaling proteins. It is structurally related to activins, which have important and often opposing regulatory effects on FSH secretion.
Unlike ovarian steroid hormones such as estradiol and progesterone, inhibin is a glycoprotein hormone.
Biologically active inhibin is a heterodimer composed of an alpha subunit linked to one of two beta subunits.
The identity of the beta subunit determines whether the molecule is inhibin A or inhibin B.
| Hormone | Subunit Composition | Important Ovarian Association |
|---|---|---|
| Inhibin A | Alpha + beta A | Corpus luteum and later stages of follicular development |
| Inhibin B | Alpha + beta B | Developing follicles, particularly during the follicular phase |
The major ovarian source of inhibin is the granulosa cell population. Granulosa cells surround the developing oocyte and form the cellular wall of the ovarian follicle.
As follicles grow and granulosa cells proliferate, their endocrine activity changes in response to gonadotropins and local ovarian regulatory factors.
Granulosa cells perform several endocrine functions. In addition to producing inhibins, they express FSH receptors and participate in estrogen synthesis through aromatization of androgen precursors supplied by theca interna cells.
Granulosa cells therefore participate simultaneously in ovarian steroidogenesis and peptide hormone feedback to the pituitary.
FSH released from the anterior pituitary binds receptors on granulosa cells and promotes follicular growth and differentiation.
FSH stimulation also contributes to granulosa-cell production of inhibin, creating a feedback relationship in which FSH stimulates ovarian activity that subsequently produces a signal capable of limiting further FSH secretion.
The principal endocrine action of inhibin is the selective suppression of FSH synthesis and secretion by gonadotroph cells of the anterior pituitary.
This function distinguishes inhibin from ovarian steroid hormones, which exert broader effects on both hypothalamic and pituitary reproductive regulation.
| Step | Process |
|---|---|
| 1 | Anterior pituitary releases FSH |
| 2 | FSH stimulates developing ovarian follicles |
| 3 | Granulosa cells increase endocrine activity |
| 4 | Granulosa cells produce inhibin |
| 5 | Inhibin reaches the anterior pituitary through the circulation |
| 6 | Inhibin suppresses FSH synthesis and secretion |
One of the defining features of inhibin is its relatively selective effect on FSH. Inhibin does not suppress LH to the same extent.
This selective regulation allows the ovary to modify FSH availability independently of some of the mechanisms controlling LH secretion.
Inhibin participates in the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus releases GnRH, which stimulates anterior pituitary gonadotrophs to release LH and FSH. These gonadotropins regulate ovarian function.
The ovaries subsequently produce estradiol, progesterone, inhibins, and other regulatory molecules that provide feedback to the reproductive axis.
Estradiol and progesterone influence both hypothalamic and pituitary components of reproductive regulation. Inhibin acts particularly as a pituitary regulator of FSH.
The combined effects of these hormones permit more precise control of gonadotropin secretion than could be achieved through steroid feedback alone.
Inhibin B is an important product of developing ovarian follicles and is particularly associated with granulosa-cell activity during the follicular phase.
Its circulating concentration provides information about the activity of the developing follicular population.
At the beginning of a new ovarian cycle, FSH concentrations rise sufficiently to recruit a cohort of follicles. As these follicles develop, granulosa cells produce increasing amounts of inhibin B.
Increasing inhibin B contributes to suppression of FSH as the follicular phase progresses.
Follicular recruitment refers to the growth of a group of ovarian follicles under gonadotropin stimulation.
FSH is particularly important for supporting granulosa-cell proliferation and follicular development during this stage.
As developing follicles produce increasing estradiol and inhibin B, circulating FSH begins to decline.
This decline is an important component of follicular selection because not all recruited follicles remain equally capable of continuing development as FSH availability decreases.
One follicle normally becomes the dominant follicle. It possesses sufficient sensitivity and steroidogenic capacity to continue developing despite declining circulating FSH concentrations.
Other follicles from the recruited cohort generally undergo atresia.
By contributing to the fall in FSH during the follicular phase, inhibin B participates indirectly in the endocrine environment associated with dominant follicle selection.
It therefore forms part of the regulatory system that helps prevent continued equivalent development of a large number of follicles during a typical ovarian cycle.
During the late follicular phase, the dominant follicle becomes the major ovarian endocrine structure. Estradiol concentrations rise markedly, while inhibin production continues to contribute to FSH regulation.
The combination of ovarian peptide and steroid feedback helps shape the characteristic gonadotropin pattern preceding ovulation.
Sustained high estradiol from the mature dominant follicle produces positive feedback leading to the midcycle LH surge. The LH surge initiates ovulation and luteinization of the follicular cells.
The endocrine profile changes substantially after the follicle becomes the corpus luteum.
Inhibin A becomes particularly important after ovulation. The corpus luteum produces inhibin A together with progesterone and estradiol.
Circulating inhibin A therefore rises during the luteal phase of the ovarian cycle.
The corpus luteum develops from the postovulatory follicle and functions as a temporary endocrine gland.
Granulosa lutein and theca lutein cells produce ovarian hormones required for luteal-phase regulation and, if conception occurs, support of early pregnancy.
During the luteal phase, inhibin A contributes to suppression of pituitary FSH. Progesterone and estradiol simultaneously provide strong negative feedback within the reproductive axis.
Together, these signals suppress gonadotropin activity while the corpus luteum remains functional.
If pregnancy does not occur, the corpus luteum regresses. Production of progesterone, estradiol, and inhibin A consequently falls.
The reduction in ovarian negative feedback permits FSH concentrations to begin increasing, helping initiate recruitment of follicles for the next ovarian cycle.
| Cycle Stage | Important Inhibin Pattern | Major Source |
|---|---|---|
| Early follicular phase | Inhibin B increases with follicular development | Developing follicles |
| Mid to late follicular phase | Inhibin B contributes to FSH suppression | Granulosa cells |
| Periovulatory period | Pattern changes with follicular maturation and luteinization | Mature follicle |
| Luteal phase | Inhibin A becomes prominent | Corpus luteum |
| Late luteal phase without pregnancy | Inhibin A falls | Regressing corpus luteum |
Inhibin and estradiol are both produced by developing ovarian follicles, but they regulate the reproductive axis through partly different mechanisms.
Estradiol participates in broader hypothalamic and pituitary feedback, whereas inhibin provides particularly important selective suppression of FSH.
The decline in FSH during follicular development cannot be attributed to inhibin alone. Estradiol and inhibin act together, along with other regulatory mechanisms, to modify pituitary FSH secretion.
This combined feedback allows ovarian follicular activity to influence subsequent gonadotropin availability.
Inhibin is considerably more selective for regulation of FSH than LH. LH secretion remains primarily controlled through GnRH stimulation and feedback from ovarian steroid hormones and other neuroendocrine mechanisms.
This difference allows FSH and LH concentrations to be regulated partly independently despite being secreted by the same anterior pituitary gonadotroph population.
Activins are proteins structurally related to inhibins and belong to the same TGF-β superfamily.
In contrast to the inhibitory effect of inhibin, activin can stimulate FSH synthesis and secretion by anterior pituitary gonadotrophs.
Whereas inhibin contains one alpha and one beta subunit, activins are formed from combinations of beta subunits.
This structural relationship allows inhibin and activin to participate in a closely connected regulatory system.
| Feature | Inhibin | Activin |
|---|---|---|
| Protein family | TGF-β superfamily | TGF-β superfamily |
| Subunits | Alpha + beta | Beta + beta |
| Major pituitary effect | Suppresses FSH | Stimulates FSH |
| Role | Negative regulation | Positive regulation |
Follistatin is another important component of the inhibin-activin regulatory system. It binds activin and reduces the ability of activin to interact with its receptors.
By neutralizing activin activity, follistatin indirectly reduces activin-mediated stimulation of FSH.
FSH regulation therefore involves a network rather than a single feedback hormone. Inhibin suppresses FSH, activin promotes FSH synthesis and secretion, and follistatin limits activin activity.
The balance among these signals contributes to fine regulation of pituitary gonadotroph function.
The anterior pituitary is the principal endocrine target of circulating inhibin. Within the anterior pituitary, inhibin acts on gonadotroph cells, the cells responsible for production of FSH and LH.
Its signaling modifies mechanisms regulating FSH synthesis and release.
Gonadotrophs are endocrine cells of the anterior pituitary that synthesize the glycoprotein hormones FSH and LH.
Their activity is controlled by hypothalamic GnRH as well as feedback signals originating from the gonads.
Inhibin regulates signaling associated with the TGF-β superfamily, particularly by opposing activin-dependent pathways.
Its actions involve interactions with cell-surface components including betaglycan and activin-related receptor systems.
Betaglycan, also known as the type III TGF-β receptor, can function as an important inhibin coreceptor.
Its interaction with inhibin facilitates antagonism of activin signaling in responsive cells.
In addition to its endocrine action on the pituitary, the inhibin-activin system participates in local regulation within the ovary.
Members of this signaling family can influence follicular development, steroidogenesis, granulosa-cell function, and communication among ovarian cell populations.
The inhibin family illustrates the overlap between endocrine and paracrine signaling. Inhibin released into blood can regulate the anterior pituitary, while related factors can act locally within ovarian tissue.
The final ovarian response therefore reflects both systemic gonadotropin signals and local regulatory mechanisms.
Activation of the hypothalamic-pituitary-gonadal axis during puberty increases gonadotropin stimulation of the ovaries and promotes follicular development.
As ovarian follicular activity increases, inhibin becomes part of the maturing feedback relationship between the ovaries and pituitary.
Before puberty, ovarian follicular activity and gonadotropin secretion differ substantially from the mature reproductive pattern.
The cyclic inhibin patterns characteristic of reproductive-age ovarian function become established with maturation of the HPG axis.
Ovarian aging is associated with progressive depletion of the follicular pool. As the number and activity of recruitable follicles decline, production of follicle-associated regulatory hormones also changes.
Declining inhibin B contributes to reduced negative feedback on pituitary FSH.
Reduced inhibin feedback is one factor contributing to increasing FSH concentrations during reproductive aging.
FSH can therefore rise before complete cessation of ovarian estrogen production.
After menopause, depletion of functional ovarian follicles markedly reduces ovarian inhibin production.
Loss of inhibin and ovarian steroid feedback contributes to the elevated gonadotropin concentrations characteristic of the postmenopausal state.
Because inhibin B is produced by developing follicles, its concentration has been investigated as an indicator of ovarian follicular activity and ovarian reserve.
However, ovarian reserve assessment is multifactorial, and inhibin B is not interpreted in isolation.
Both inhibin B and anti-Müllerian hormone (AMH) are produced by granulosa cells, but their patterns of production and clinical applications differ.
AMH is produced particularly by preantral and small antral follicles and is widely used as one marker of the remaining follicular pool.
Pregnancy substantially changes inhibin physiology. In addition to ovarian production early in pregnancy, placental tissues contribute to circulating inhibin, particularly inhibin A.
Maternal inhibin concentrations therefore reflect a different endocrine environment from that of the nonpregnant ovarian cycle.
The placenta becomes an important source of inhibin A during pregnancy.
Measurement of inhibin A can consequently have applications in prenatal biochemical screening when interpreted together with other maternal markers and clinical information.
Inhibin also has an important role in male reproductive endocrinology. In males, Sertoli cells of the testes produce predominantly inhibin B.
Testicular inhibin B provides negative feedback on pituitary FSH secretion and reflects aspects of Sertoli-cell and seminiferous tubular function.
| Feature | Ovary | Testis |
|---|---|---|
| Principal producing cell | Granulosa cell | Sertoli cell |
| Important form | Inhibin A and inhibin B | Predominantly inhibin B |
| Primary endocrine target | Anterior pituitary | Anterior pituitary |
| Major effect | Suppression of FSH | Suppression of FSH |
Because inhibins are produced by particular gonadal and placental tissues, circulating concentrations can provide information about the activity of these tissues in selected clinical contexts.
Interpretation depends on age, sex, menstrual-cycle phase, pregnancy status, menopausal status, and the specific inhibin form measured.
Some ovarian granulosa cell tumors produce inhibin. Measurement of inhibin A or inhibin B can therefore be useful as a tumor marker in selected patients with these neoplasms.
The usefulness of a particular marker depends on the tumor and clinical context.
Granulosa cell tumors arise from ovarian sex cord-stromal tissue and may retain endocrine functions of normal granulosa cells.
They can produce inhibins and, in some cases, estrogenic hormones, resulting in endocrine manifestations in addition to the effects of the ovarian mass itself.
Reduction in functional granulosa-cell mass can decrease inhibin production. The resulting loss of negative feedback can permit increased pituitary FSH secretion.
This relationship is particularly relevant to understanding reproductive aging and ovarian failure.
When ovarian follicular function is substantially impaired, reduced ovarian feedback contributes to elevated gonadotropin concentrations.
Loss of inhibin-mediated suppression is one component of the increase in FSH that accompanies reduced ovarian function.
FSH often becomes particularly elevated when ovarian function declines because it is regulated not only by ovarian steroid hormones but also by inhibin.
Reduction of both steroid and inhibin feedback therefore has substantial effects on FSH regulation.
Most recruited ovarian follicles do not ovulate. As nondominant follicles undergo atresia, their granulosa-cell function declines.
Changes in the population of active granulosa cells contribute to changing patterns of ovarian peptide hormone production throughout the cycle.
The dominant follicle maintains development in an environment of falling FSH. Its granulosa cells become highly differentiated and increasingly capable of supporting the endocrine events leading to ovulation.
Inhibin production is part of the feedback environment accompanying this follicular selection process.
During pharmacological stimulation of multiple ovarian follicles, the number and activity of granulosa cells can differ markedly from those of a spontaneous single-dominant-follicle cycle.
Concentrations of granulosa-cell products, including inhibins, may consequently change in association with the ovarian response.
Inhibin should be distinguished structurally and functionally from estradiol and progesterone. Estradiol and progesterone are cholesterol-derived steroid hormones, while inhibin is a dimeric glycoprotein.
This difference affects synthesis, secretion, receptor interactions, and transport characteristics.
As a protein hormone, inhibin is secreted into extracellular fluid and subsequently enters the circulation. It does not require the extensive plasma carrier-protein binding characteristic of hydrophobic steroid hormones.
Blood transports ovarian inhibin to its endocrine target in the anterior pituitary.
| Feature | Inhibin | Estrogen |
|---|---|---|
| Hormone type | Glycoprotein | Steroid |
| Important ovarian source | Granulosa cells and corpus luteum | Granulosa cells using theca-derived androgen precursors; corpus luteum |
| Major pituitary effect | Selective suppression of FSH | Broader feedback on reproductive axis |
| Major systemic effects | Primarily reproductive endocrine regulation | Extensive reproductive and nonreproductive actions |
| Major forms | Inhibin A and inhibin B | Estradiol, estrone, estriol |
| Feature | Inhibin | Progesterone |
|---|---|---|
| Hormone class | Glycoprotein | Steroid |
| Major luteal source | Corpus luteum | Corpus luteum |
| Primary feedback characteristic | Selective FSH suppression | Hypothalamic-pituitary negative feedback |
| Major reproductive role | Gonadotropin regulation | Preparation and maintenance of secretory endometrium and reproductive regulation |
| Ovarian Hormone | Important Source | Major Feedback Role |
|---|---|---|
| Estradiol | Developing follicle and corpus luteum | Negative feedback and preovulatory positive feedback |
| Progesterone | Corpus luteum | Predominantly negative feedback during luteal phase |
| Inhibin B | Developing follicles | FSH suppression, especially associated with follicular phase |
| Inhibin A | Corpus luteum and follicular tissue | FSH suppression, particularly prominent during luteal phase |
Selective FSH suppression allows the ovary to communicate information about follicular activity back to the anterior pituitary.
As granulosa-cell activity increases, inhibin signals that follicular tissue is responding to FSH. Reduction of further FSH stimulation helps shape the number and developmental fate of follicles within the cycle.
Follicular development depends on coordinated interactions among FSH, LH, ovarian steroid hormones, inhibins, activins, and numerous local growth factors.
Inhibin is therefore one component of a larger regulatory network rather than an isolated controller of ovarian function.
| Feature | Key Point |
|---|---|
| Hormone type | Glycoprotein |
| Protein family | TGF-β superfamily |
| Major ovarian source | Granulosa cells |
| Major forms | Inhibin A and inhibin B |
| Principal endocrine target | Anterior pituitary gonadotrophs |
| Principal endocrine effect | Suppression of FSH synthesis and secretion |
| Follicular-phase form | Inhibin B is particularly important |
| Luteal-phase form | Inhibin A is particularly prominent |
| Related stimulatory protein | Activin |
| Activin-binding regulator | Follistatin |
Inhibin provides an important endocrine connection between the functional state of ovarian follicles and the anterior pituitary. Because granulosa cells are major producers of inhibin, circulating inhibin concentrations reflect aspects of the activity of the follicular compartment and, after ovulation, the corpus luteum.
During the follicular phase, FSH promotes granulosa-cell development and endocrine activity. Growing follicles subsequently produce inhibin B, which contributes to suppression of further FSH secretion. Together with rising estradiol, this feedback helps create the declining FSH environment associated with selection of a dominant follicle from the initially recruited follicular cohort.
After ovulation, the endocrine organization of the ovary changes as the ruptured follicle becomes the corpus luteum. Inhibin A becomes more prominent and contributes to suppression of FSH during the luteal phase alongside progesterone and estradiol. When the corpus luteum regresses, declining inhibin and steroid hormone concentrations remove this negative feedback, allowing FSH to begin rising for the next cycle.
The inhibin system also demonstrates that gonadal feedback involves more than steroid hormones. Estradiol and progesterone provide broad reproductive feedback, while inhibin offers relatively selective control of FSH. Activin and follistatin add further levels of regulation, producing a network capable of fine control of anterior pituitary gonadotroph function.
Changes in inhibin physiology are also relevant across the reproductive lifespan. Declining follicular activity during ovarian aging reduces inhibin feedback and contributes to rising FSH concentrations. Inhibin production by granulosa-cell tumors and placental tissues also gives inhibin clinical significance beyond normal ovarian-cycle physiology. Its central role remains the communication of gonadal activity to the pituitary, particularly through selective regulation of FSH.